IKZF1 and acute lymphoblastic leukemia: In the Children’s Oncology Group (COG) P9906 study, a study of children with high-risk, Ph-negative B-ALL, missense, frameshift, and nonsense mutations predicted to alter IKAROS function were detected in approximately 2% of patients [5,35].